The effect of C7-T1 fusion on clinical and patient-reported outcomes in ACDF patients: A quality outcomes database study

Background: The C7-T1 segment poses challenges in spinal surgery due to its biomechanical transition from the mobile cervical spine to the rigid thoracic spine, with concerns about subsidence from stress-shielding of the T1 superior endplate by the first rib. The impact of fusing C7-T1 on outcomes remains unclear relative to other levels during anterior cervical discectomy and fusion (ACDF). Objective: In a cohort of patients undergoing ACDF, we sought to determine the impact of C7-T1 fusion on patient-reported outcome measures (PROMs) and clinical outcomes. Methods: A retrospective cohort study using the Quality Outcome Database was conducted for patients who underwent primary single- or 2-level ACDF. The primary exposure variable was fusion of C7-T1. The primary outcome was 3-month and 12-month PROMs, including numeric rating scale for neck and arm pain, neck disability index, quality-adjusted life year (QALY) score, and patient satisfaction. Secondary outcomes included 30-day complications and 3-month readmissions and reoperations. Multivariable regression models were fitted for each outcome, controlling for baseline variables. Results: Of 12,240 patients (age 55.8 ± 11.6 years; 48.7% male) undergoing ACDF, 4736 (38.7%) had C7-T1 fusion. On multivariable regression, fusion of C7-T1 was associated with a greater 3-month QALY score (odds ratio [OR] = 1.142; 95% confidence interval [CI]: 1.055–1.237; p < 0.001) and lower rate of readmission (OR = 0.760; 95% CI: 0.625–0.924; p = 0.006), with no association to other PROMs, patient satisfaction, complications, and reoperation ( p > 0.05). On subanalysis of 4103 myelopathic patients, C7-T1 fusion was only associated with lower odds of 3-month readmission (OR = 0.602; 95% CI: 0.420–0.864; p = 0.006). Conclusion: C7–T1 fusion was associated with a better 3-month QALY score and a lower rate of readmission. Myelopathy patients with C7-T1 fusion were also less likely to be readmitted within 3 months of surgery. C7-T1 fusion was not associated with any other outcome. Our results suggest comparable outcomes when fusing C7-T1, which may be useful when counseling patients facing surgery for pathology at this level.

Authors

Institutions

Publication Details

Journal
Spine Research
Published
2026-03-24
DOI
https://doi.org/10.1097/br9.0000000000000025
Primary Topic
Cervical and Thoracic Myelopathy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The effect of C7-T1 fusion on clinical and patient-reported outcomes in ACDF patients: A quality outcomes database study

Omar Zakieh, Jacquelyn S. Pennings, Raymond Joseph Gardocki, Byron F. Stephens et al.
Spine Research
Cervical and Thoracic Myelopathy
article

The effect of C7-T1 fusion on clinical and patient-reported outcomes in ACDF patients: A quality outcomes database study

Omar Zakieh, Jacquelyn S. Pennings, Raymond Joseph Gardocki, Byron F. Stephens, Hui Nian, Maryam Y. Jawid, Mitchell Bowers, M. Wharton Young, James F. Bathon, Amir M. Abtahi, Julian G. Lugo-Pico, Scott L. Zuckerman
article en

Abstract

Background: The C7-T1 segment poses challenges in spinal surgery due to its biomechanical transition from the mobile cervical spine to the rigid thoracic spine, with concerns about subsidence from stress-shielding of the T1 superior endplate by the first rib. The impact of fusing C7-T1 on outcomes remains unclear relative to other levels during anterior cervical discectomy and fusion (ACDF). Objective: In a cohort of patients undergoing ACDF, we sought to determine the impact of C7-T1 fusion on patient-reported outcome measures (PROMs) and clinical outcomes. Methods: A retrospective cohort study using the Quality Outcome Database was conducted for patients who underwent primary single- or 2-level ACDF. The primary exposure variable was fusion of C7-T1. The primary outcome was 3-month and 12-month PROMs, including numeric rating scale for neck and arm pain, neck disability index, quality-adjusted life year (QALY) score, and patient satisfaction. Secondary outcomes included 30-day complications and 3-month readmissions and reoperations. Multivariable regression models were fitted for each outcome, controlling for baseline variables. Results: Of 12,240 patients (age 55.8 ± 11.6 years; 48.7% male) undergoing ACDF, 4736 (38.7%) had C7-T1 fusion. On multivariable regression, fusion of C7-T1 was associated with a greater 3-month QALY score (odds ratio [OR] = 1.142; 95% confidence interval [CI]: 1.055–1.237; p < 0.001) and lower rate of readmission (OR = 0.760; 95% CI: 0.625–0.924; p = 0.006), with no association to other PROMs, patient satisfaction, complications, and reoperation ( p > 0.05). On subanalysis of 4103 myelopathic patients, C7-T1 fusion was only associated with lower odds of 3-month readmission (OR = 0.602; 95% CI: 0.420–0.864; p = 0.006). Conclusion: C7–T1 fusion was associated with a better 3-month QALY score and a lower rate of readmission. Myelopathy patients with C7-T1 fusion were also less likely to be readmitted within 3 months of surgery. C7-T1 fusion was not associated with any other outcome. Our results suggest comparable outcomes when fusing C7-T1, which may be useful when counseling patients facing surgery for pathology at this level.

Spine Research
Vanderbilt University (US), Neurological Surgery (US), Vanderbilt University Medical Center (US)
Openalex Percentile: Top 10%
Cervical and Thoracic Myelopathy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.